FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W41563388> ?p ?o ?g. }

• W41563388 endingPage "83" @default.
• W41563388 startingPage "74" @default.
• W41563388 abstract "The administration of sodium 2,3-dimercapto-1-propane sulfonate (DMPS) to humans chronically exposed to inorganic arsenic in their drinking water resulted in the increased urinary excretion of arsenic, the appearance and identification of monomethylarsonous acid (MMA(III)) in their urine, and a large decrease in the concentration and percentage of urinary dimethylarsinic acid (DMA). This is the first time that MMA(III) has been detected in the urine. In vitro biochemical experiments were then designed and performed to understand the urinary appearance of MMA(III) and decrease of DMA. The DMPS-MMA(III) complex was not active as a substrate for the MMA(III) methyltransferase. The experimental results support the hypothesis that DMPS competes with endogenous ligands for MMA(III), forming a DMPS-MMA complex that is readily excreted in the urine and points out the need for studying the biochemical toxicology of MMA(III). It should be emphasized that MMA(III) was excreted in the urine only after DMPS administration. The results of these studies raise many questions about the potential central role of MMA(III) in the toxicity of inorganic arsenic and to the potential involvement of MMA(III) in the little-understood etiology of hyperkeratosis, hyperpigmentation, and cancer that can result from chronic inorganic arsenic exposure." @default.
• W41563388 created "2016-06-24" @default.
• W41563388 creator A5000491824 @default.
• W41563388 creator A5010924682 @default.
• W41563388 creator A5021233362 @default.
• W41563388 creator A5021955269 @default.
• W41563388 creator A5022764571 @default.
• W41563388 creator A5040797712 @default.
• W41563388 creator A5041773389 @default.
• W41563388 creator A5042714572 @default.
• W41563388 creator A5043847939 @default.
• W41563388 creator A5044398853 @default.
• W41563388 creator A5048787291 @default.
• W41563388 creator A5052077864 @default.
• W41563388 creator A5052871387 @default.
• W41563388 creator A5057826545 @default.
• W41563388 creator A5064411866 @default.
• W41563388 creator A5075882805 @default.
• W41563388 creator A5090656265 @default.
• W41563388 date "2000-05-01" @default.
• W41563388 modified "2023-10-01" @default.
• W41563388 title "DMPS–Arsenic Challenge Test" @default.
• W41563388 cites W101730308 @default.
• W41563388 cites W1556934473 @default.
• W41563388 cites W1967850583 @default.
• W41563388 cites W1974361577 @default.
• W41563388 cites W1974381826 @default.
• W41563388 cites W1978665041 @default.
• W41563388 cites W1978879125 @default.
• W41563388 cites W1984958416 @default.
• W41563388 cites W2008679004 @default.
• W41563388 cites W2018539752 @default.
• W41563388 cites W2028785038 @default.
• W41563388 cites W2028855377 @default.
• W41563388 cites W2045563402 @default.
• W41563388 cites W2045823138 @default.
• W41563388 cites W2057426634 @default.
• W41563388 cites W2060187730 @default.
• W41563388 cites W2062548565 @default.
• W41563388 cites W2069822254 @default.
• W41563388 cites W2077518922 @default.
• W41563388 cites W2089037794 @default.
• W41563388 cites W2124087224 @default.
• W41563388 cites W2141549113 @default.
• W41563388 cites W2148040885 @default.
• W41563388 cites W2167586301 @default.
• W41563388 cites W2168284337 @default.
• W41563388 cites W2174484416 @default.
• W41563388 cites W83286318 @default.
• W41563388 cites W2281046349 @default.
• W41563388 doi "https://doi.org/10.1006/taap.2000.8922" @default.
• W41563388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10814555" @default.
• W41563388 hasPublicationYear "2000" @default.
• W41563388 type Work @default.
• W41563388 sameAs 41563388 @default.
• W41563388 citedByCount "123" @default.
• W41563388 countsByYear W415633882012 @default.
• W41563388 countsByYear W415633882013 @default.
• W41563388 countsByYear W415633882014 @default.
• W41563388 countsByYear W415633882015 @default.
• W41563388 countsByYear W415633882016 @default.
• W41563388 countsByYear W415633882017 @default.
• W41563388 countsByYear W415633882018 @default.
• W41563388 countsByYear W415633882022 @default.
• W41563388 countsByYear W415633882023 @default.
• W41563388 crossrefType "journal-article" @default.
• W41563388 hasAuthorship W41563388A5000491824 @default.
• W41563388 hasAuthorship W41563388A5010924682 @default.
• W41563388 hasAuthorship W41563388A5021233362 @default.
• W41563388 hasAuthorship W41563388A5021955269 @default.
• W41563388 hasAuthorship W41563388A5022764571 @default.
• W41563388 hasAuthorship W41563388A5040797712 @default.
• W41563388 hasAuthorship W41563388A5041773389 @default.
• W41563388 hasAuthorship W41563388A5042714572 @default.
• W41563388 hasAuthorship W41563388A5043847939 @default.
• W41563388 hasAuthorship W41563388A5044398853 @default.
• W41563388 hasAuthorship W41563388A5048787291 @default.
• W41563388 hasAuthorship W41563388A5052077864 @default.
• W41563388 hasAuthorship W41563388A5052871387 @default.
• W41563388 hasAuthorship W41563388A5057826545 @default.
• W41563388 hasAuthorship W41563388A5064411866 @default.
• W41563388 hasAuthorship W41563388A5075882805 @default.
• W41563388 hasAuthorship W41563388A5090656265 @default.
• W41563388 hasConcept C126322002 @default.
• W41563388 hasConcept C172507514 @default.
• W41563388 hasConcept C178790620 @default.
• W41563388 hasConcept C185592680 @default.
• W41563388 hasConcept C195289149 @default.
• W41563388 hasConcept C2777056448 @default.
• W41563388 hasConcept C2780026642 @default.
• W41563388 hasConcept C29730261 @default.
• W41563388 hasConcept C502230775 @default.
• W41563388 hasConcept C55493867 @default.
• W41563388 hasConcept C71924100 @default.
• W41563388 hasConcept C77411442 @default.
• W41563388 hasConcept C98274493 @default.
• W41563388 hasConceptScore W41563388C126322002 @default.
• W41563388 hasConceptScore W41563388C172507514 @default.

• next